DigestRedComo funciona
Red
/
Empresas
C₂
No verificado

C₂N Diagnostics, LLC

Sobre qué escribimos

BiotecnologíaCienciaIndustriaSaludSanidad

24 Comunicados de prensa

Ver todos los comunicados de prensa
21/09/2026
Industria
Asociaciones/Profesionales
Tercera edad
Ciencia
Higiene alimentaria
Sanidad
Familia
Ir de compras
Material médico sanitario
Medicina - Varios
Salud
C2N Diagnostics Expands Global Partnerships in United Kingdom on World Alzheimer’s Day, Joins Cambridge Cognition and The Alzheimer's Trust to Improve Alzheimer's Disease Diagnosis
Fuente
C₂N Diagnostics, LLC
Editor
Business Wire
1.00
0
18/09/2026
‘Live Long and Prosper’: Nimoy-Knight Foundation Selects C2N’s CEO and Co-Founder for Prestigious Award Following Alzheimer’s Disease Blood Test FDA Clearance
Fuente
C₂N Diagnostics, LLC
Editor
Business Wire
1.00
0
20/08/2026
Multimedia
Industria
Sanidad
Tercera edad
Ciencia
Farmacéutica
Psiquiatría
Material médico sanitario
Ir de compras
Biotecnología
Medicina - Varios
Higiene alimentaria
Salud
FDA Clears C2N Diagnostics’ PrecivityAD2® — First Alzheimer’s Blood Test for Adults with Cognitive Symptoms as Young as 40
Fuente
C₂N Diagnostics, LLC
Editor
Business Wire
1.00
0
29/07/2026
Industria
Ciencia
Psiquiatría
Higiene alimentaria
Medicina - Varios
Sanidad
Biotecnología
Farmacéutica
Salud
United Kingdom Researchers Integrate C2N’s PrecivityAD2® Blood Test Into the Alzheimer’s Disease Diagnostic Care Pathway
Fuente
C₂N Diagnostics, LLC
Editor
Business Wire
1.00
0
09/07/2026
Industria
Ciencia
Sanidad
Ir de compras
Medicina - Varios
Biotecnología
Tercera edad
Salud
Anthem Establishes Coverage of C2N Diagnostics’ PrecivityAD2® Blood Test for Alzheimer's Disease Evaluation
Fuente
C₂N Diagnostics, LLC
Editor
Business Wire
1.00
0
01/06/2026
Biotecnología
Sanidad
Psiquiatría
Salud
Industria
C2N Diagnostics and SouthGenetics Partner to Enable Broader Access to Precivity® Blood Tests for Alzheimer’s Disease Assessment in Latin America, Caribbean
Fuente
C₂N Diagnostics, LLC
Editor
Business Wire
1.00
0
19/03/2026
Industria
Psiquiatría
Sanidad
Ciencia
Biotecnología
Ir de compras
Medicina - Varios
Higiene alimentaria
Salud
Farmacéutica
Tercera edad
C2N Diagnostics Highlights First Use of Its eMTBR-tau243 Plasma Assay in Evoke/Evoke+ Phase 3 Dataset for Prediction of Cognitive and Functional Decline in Patients With Early Symptomatic Alzheimer’s Disease
Fuente
C₂N Diagnostics, LLC
Editor
Business Wire
1.00
0
11/03/2026
Mercado laboral
Industria
Farmacéutica
Sanidad
Material médico sanitario
Salud
C2N Diagnostics Enters South Korean Market Through Partnership with BeauBrain Healthcare to Offer Precivity™ Portfolio of Blood Tests to Help Doctors Diagnose Alzheimer’s Disease
Fuente
C₂N Diagnostics, LLC
Editor
Business Wire
1.00
0
13/11/2025
Psiquiatría
Salud
Ciencia
Eventos
C2N Diagnostics and WashU Medicine Teams Receive Prestigious Award from Human Proteome Organization
Fuente
C₂N Diagnostics, LLC
Editor
Business Wire
1.00
0
25/09/2025
Industria
Sanidad
Tercera edad
Medicina - Varios
Ciencia
Biotecnología
Ir de compras
Salud
New Research Reinforces C2N’s PrecivityAD2™ Blood Test as a Highly Accurate Tool to Detect Brain Amyloid Pathology in Symptomatic Patients
Fuente
C₂N Diagnostics, LLC
Editor
Business Wire
1.00
0

Detalles de contacto

Redes sociales

Seguidores
0
Compatibilidad
0